Sphingosine-1-phosphate

Characterization of its inhibition of platelet aggregation

Desmond Nugent, Yan Xu

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

In this study, the ability of sphingosine-1-phosphate (S1P) to modulate platelet aggregation induced by other agents in platelet-rich plasma (PRP) was investigated. S1P alone did not stimulate platelet aggregation in PRP. S1P inhibited the platelet aggregation induced by the TRAP peptide (6.75 μM), noradrenaline (NA; 12.5 μM) and the Ca2+ ionophore (5.0-9.5 μM). S1P also increased the response time of platelets to arachidonic acid (AA), but decreased the response time to PMA. S1P displayed a dual effect on sodium fluoride (NaF)-induced platelet aggregation and had no effect on the aggregation induced by ADP or lysophosphatidic acid (LPA). Furthermore, S1P blocked the synergistic interaction of oleyol-lysophosphatidic acid (O-LPA) with the TRAP peptide or noradrenaline, while the synergistic interaction of O-LPA with ADP remained largely unaffected.

Original languageEnglish (US)
Pages (from-to)226-232
Number of pages7
JournalPlatelets
Volume11
Issue number4
StatePublished - 2000
Externally publishedYes

Fingerprint

Platelet Aggregation
Thrombin Receptors
Platelet-Rich Plasma
Adenosine Diphosphate
Reaction Time
Norepinephrine
Sodium Fluoride
Aptitude
Ionophores
Arachidonic Acid
sphingosine 1-phosphate
Inhibition (Psychology)
Blood Platelets
lysophosphatidic acid

Keywords

  • Platelet aggregation
  • Platelet-rich plasma
  • Sphingosine-1-phosphate

ASJC Scopus subject areas

  • Hematology
  • Cell Biology

Cite this

Sphingosine-1-phosphate : Characterization of its inhibition of platelet aggregation. / Nugent, Desmond; Xu, Yan.

In: Platelets, Vol. 11, No. 4, 2000, p. 226-232.

Research output: Contribution to journalArticle

@article{863038a8f14741c88f3b5099fe51a69c,
title = "Sphingosine-1-phosphate: Characterization of its inhibition of platelet aggregation",
abstract = "In this study, the ability of sphingosine-1-phosphate (S1P) to modulate platelet aggregation induced by other agents in platelet-rich plasma (PRP) was investigated. S1P alone did not stimulate platelet aggregation in PRP. S1P inhibited the platelet aggregation induced by the TRAP peptide (6.75 μM), noradrenaline (NA; 12.5 μM) and the Ca2+ ionophore (5.0-9.5 μM). S1P also increased the response time of platelets to arachidonic acid (AA), but decreased the response time to PMA. S1P displayed a dual effect on sodium fluoride (NaF)-induced platelet aggregation and had no effect on the aggregation induced by ADP or lysophosphatidic acid (LPA). Furthermore, S1P blocked the synergistic interaction of oleyol-lysophosphatidic acid (O-LPA) with the TRAP peptide or noradrenaline, while the synergistic interaction of O-LPA with ADP remained largely unaffected.",
keywords = "Platelet aggregation, Platelet-rich plasma, Sphingosine-1-phosphate",
author = "Desmond Nugent and Yan Xu",
year = "2000",
language = "English (US)",
volume = "11",
pages = "226--232",
journal = "Platelets",
issn = "0953-7104",
publisher = "Informa Healthcare",
number = "4",

}

TY - JOUR

T1 - Sphingosine-1-phosphate

T2 - Characterization of its inhibition of platelet aggregation

AU - Nugent, Desmond

AU - Xu, Yan

PY - 2000

Y1 - 2000

N2 - In this study, the ability of sphingosine-1-phosphate (S1P) to modulate platelet aggregation induced by other agents in platelet-rich plasma (PRP) was investigated. S1P alone did not stimulate platelet aggregation in PRP. S1P inhibited the platelet aggregation induced by the TRAP peptide (6.75 μM), noradrenaline (NA; 12.5 μM) and the Ca2+ ionophore (5.0-9.5 μM). S1P also increased the response time of platelets to arachidonic acid (AA), but decreased the response time to PMA. S1P displayed a dual effect on sodium fluoride (NaF)-induced platelet aggregation and had no effect on the aggregation induced by ADP or lysophosphatidic acid (LPA). Furthermore, S1P blocked the synergistic interaction of oleyol-lysophosphatidic acid (O-LPA) with the TRAP peptide or noradrenaline, while the synergistic interaction of O-LPA with ADP remained largely unaffected.

AB - In this study, the ability of sphingosine-1-phosphate (S1P) to modulate platelet aggregation induced by other agents in platelet-rich plasma (PRP) was investigated. S1P alone did not stimulate platelet aggregation in PRP. S1P inhibited the platelet aggregation induced by the TRAP peptide (6.75 μM), noradrenaline (NA; 12.5 μM) and the Ca2+ ionophore (5.0-9.5 μM). S1P also increased the response time of platelets to arachidonic acid (AA), but decreased the response time to PMA. S1P displayed a dual effect on sodium fluoride (NaF)-induced platelet aggregation and had no effect on the aggregation induced by ADP or lysophosphatidic acid (LPA). Furthermore, S1P blocked the synergistic interaction of oleyol-lysophosphatidic acid (O-LPA) with the TRAP peptide or noradrenaline, while the synergistic interaction of O-LPA with ADP remained largely unaffected.

KW - Platelet aggregation

KW - Platelet-rich plasma

KW - Sphingosine-1-phosphate

UR - http://www.scopus.com/inward/record.url?scp=0033926364&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033926364&partnerID=8YFLogxK

M3 - Article

VL - 11

SP - 226

EP - 232

JO - Platelets

JF - Platelets

SN - 0953-7104

IS - 4

ER -